Saras Capital

Investor profile | Builders Republic

About

Saras Capital is a UK‑based investment firm that invests at the intersection of biology and AI, focusing on discovery platforms, “biotech‑in‑a‑garage” startups, and vertical AI solutions for biopharma. Founded in 2020 and led by Nadav Rosenberg, it backs exceptional scientific talent and aims to be a highly supportive minority shareholder.

Key facts

Type
Venture Capital
Stages
Seed,Series A
Sectors
Healthcare,Biotech,AI & Automation
Headquarters
UK
Offices
London
Geographic focus
France,Europe
Lead / Follow
Lead / co-lead
Ticket size
0.3M€ – 1M€
Founded
2020

Track record

  • Total investments: 25

Notable investments in France

Kyron.bio, Generare.bio

Key differentiators

Sector Specialist